-
Generic Threat Hanging Over CELG - Analyst Blog
Friday, August 27, 2010 - 9:03am | 720Celgene Corporation (CELG) could receive notification shortly regarding a patent challenge for its lead drug Revlimid (lenalidomide) 25 mg capsules. The company announced that according to a post on the site of the US Food and Drug Administration (FDA), a generic company is looking to launch a...
-
Citigroup (C): Cramer’s “favorite speculation” stock
Thursday, August 26, 2010 - 8:08am | 1730Jim Cramer sounded the bullish horn on Citigroup (NYSE:C) Tuesday night, telling his Mad Money viewers that the beleaguered banking name is “the most undervalued bank in America.” The CNBC host also said Citi “remains my favorite speculation [stock].” Cramer did add the caveat that investors will...
-
Calls Purchased on Advanced Auto Parts (AAP)
Monday, August 23, 2010 - 12:53pm | 181Shares of Advanced Auto Parts Inc. (NYSE: AAP) are lower on the session by 0.63%, currently trading at $55.54. The stock has been moving largely higher over the past six months and is trading near its 52-weeks high of $56.21, which it hit earlier in the session. Options traders are betting on...
-
Celgene's Revlimid Marches on - Analyst Blog
Monday, August 23, 2010 - 8:20am | 515Celgene Corporation (CELG) received a boost with its lead product Revlimid gaining approval in Japan for the treatment of deletion 5q myelodysplastic syndromes (MDS). The approval comes close on the heels of the drug receiving Japanese approval in combination with dexamethasone for treating...
-
Momentum Stock Picks-Aug.19, 2010 - Zacks Rank Buys
Thursday, August 19, 2010 - 6:52pm | 90HILL-ROM HLDGS (HRC): Free Stock Analysis Report MONRO MUFFLER (MNRO): Free Stock Analysis Report Zacks Investment Research
-
America's Car-Mart Beats on Top and Bottom Lines (CRMT)
Thursday, August 19, 2010 - 5:08pm | 125America's Car-Mart Inc. (CRMT) reports Q2 EPS of $0.70 versus estimates of $0.68. America's Car-Mart Inc. reports revenues of $91.5 million versus estimates of $91.47 million. Revenues increased 9.2% year over year. The company reported debt to equity of 24.9% and debt to finance receivables of 16...
-
Zacks Analyst Blog Highlights: Celgene, Abraxis BioScience, Johnson & Johnson, SuperGen and Biogen Idec - Press Releases
Wednesday, August 18, 2010 - 4:13pm | 1345For Immediate Release Chicago, IL – August 18, 2010 – Zacks.com Analyst Blog features: Celgene Corporation (CELG), Abraxis BioScience Inc. (ABII), Johnson & Johnson (JNJ), SuperGen (SUPG) and Biogen Idec (BIIB ). Here are highlights from Tuesday’s Analyst Blog: Celgene Evenly Poised We are...
-
NASDAQ Stocks Hitting 52-Week Highs (INTX, LMAT, MNRO, THRD)
Wednesday, August 18, 2010 - 12:14pm | 154Intersections Inc (NASDAQ: INTX) shares reached $9.74 to create a new 52-week high, before falling to $9.65, representing a 5.12% gain. The Board of Directors of INTX had declared a regular quarterly cash dividend of $0.15 per share. LeMaitre Vascular Inc (NASDAQ: LMAT) shares rose 3.53% to touch a...
-
Zacks Analyst Blog Highlights: Cardinal Health, Cumberland Pharmaceuticals, McKesson, AmerisourceBergen and Advance Auto Parts - Press Releases
Wednesday, August 18, 2010 - 10:23am | 1231For Immediate Release Chicago, IL – August 18, 2010 – Zacks.com Analyst Blog features: Cardinal Health (CAH), Cumberland Pharmaceuticals (CPIX), McKesson Corporation (MCK), AmerisourceBergen Corporation (ABC) and Advance Auto Parts Inc. (AAP ). Here are highlights from Tuesday’s Analyst Blog:...
-
Earnings Scorecard: Advance Auto Parts - Analyst Blog
Tuesday, August 17, 2010 - 4:38pm | 1158Advance Auto Parts Inc. (AAP) reported second-quarter results on August 11, beating the Zacks Consensus Estimate by 14 cents per share. The market reacted favorably, with its share price rising after the release. Analysts were highly optimistic given the company’s improved results and revised...
-
Celgene Evenly Poised - Analyst Blog
Tuesday, August 17, 2010 - 4:38pm | 981We are maintaining our Neutral recommendation on Celgene Corporation (CELG) with a target price of $58. Celgene, founded in 1986 and headquartered in Summit, NJ, focuses on the discovery, development and commercialization of drugs in the areas of cancer and immune/inflammatory diseases. The...
-
Advance Auto Parts Outpaces Estimates - Analyst Blog
Tuesday, August 17, 2010 - 12:34pm | 420Advance Auto Parts Inc. (AAP) showed an increase in profit to $100.9 million or $1.16 per share in the second quarter of 2010, ended July 17, 2010. That compares with $80.3 million or 83 cents in the year-ago quarter. The automotive retailer outpaced the Zacks Consensus Estimate of $1.02 per share...
-
Monro Muffler Brake, Inc. - Momentum
Tuesday, August 17, 2010 - 12:34pm | 716Monro Muffler Brake, Inc. (MNRO) recently jumped to a new multi-year high after reporting better than expected Q2 results on July 22 that included a 5% earnings surprise for this Zacks #2 rank stock. Second-Quarter Results Revenue for the period was up 24% from last year to $158 million, with...
-
Zacks Releases Four Powerful ''Buy'' Stocks: Rockwood Holdings, iGate, Monro Muffler Brake and DSW - Press Releases
Tuesday, August 17, 2010 - 11:47am | 1334For Immediate Release Chicago, IL – August 16, 2010 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive...
-
Zacks Analyst Blog Highlights: Biovail, Valeant Pharma, DeVry, Advance Auto Parts and Halliburton Company - Press Releases
Tuesday, August 17, 2010 - 11:47am | 1379For Immediate Release Chicago, IL – August 16, 2010 – Zacks.com Analyst Blog features: Biovail Corporation (BVF), Valeant Pharma (VRX), DeVry Inc. (DV), Advance Auto Parts Inc. (AAP) and Halliburton Company (HAL ). Here are highlights from Friday’s Analyst Blog: Biovail Beats in Q2 Biovail...